DAVID BEAL: Open Payments
NPI 1508536616 · NORTH HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 42 payments from 18 companies in 2025. Trend: 2023 $1,023 · 2024 $1,195 · 2025 $1,005
Food & beverage: $987Education: $18
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 8 | $190 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| Amgen Inc. | 6 | $106 |
| PFIZER INC. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| ABBVIE INC. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
Products named: ACCRUFER, Symbravo, DUPIXENT, M-M-R II, GEMTESA, SHINGRIX, OTEZLA, Kerendia.
Industry payments across CA — which companies pay providers there.
